| Line Item | 2023-12-31 | Y/Y |
|---|---|---|
| Revenue | $22.8M | +93.2% |
| Cost of Revenue | $19.0M | +159.1% |
| Gross Profit | $3.8M | -14.2% |
| R&D Expense | $156.1M | +26.4% |
| SG&A Expense | $65.4M | +3.7% |
| Operating Income | -$275.6M | -19.8% |
| Pre-tax Income | -$180.1M | -27.2% |
| Income Tax | $0 | — |
| Net Income | -$58.4M |
| Line Item | 2023-12-31 | Y/Y |
|---|---|---|
| Cash & Equivalents | $120.3M | -44.8% |
| Short-term Investments | $0 | -100.0% |
| Accounts Receivable | $10.1M | -9.6% |
| Current Assets | $154.5M | -45.7% |
| Total Assets | $224.9M | -35.5% |
| Current Liabilities | $87.5M | +126.8% |
| Total Liabilities | $95.5M | +33.5% |
| Line Item | 2023-12-31 | Y/Y |
|---|---|---|
| Operating Cash Flow | -$183.3M | -23.3% |
| Capital Expenditures | $1.7M | -26.0% |
| Investing Cash Flow | $48.3M | +192.2% |
| Financing Cash Flow | $16.1M | -95.6% |
| Free Cash Flow | -$185.0M | -22.6% |
| -125.2% |
| EPS (Basic) | -$0.80 | -56.9% |
| EPS (Diluted) | -$0.80 | -56.9% |
| Stockholders' Equity |
| $93.5M |
| -18.5% |